Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Polpharma

02 1Dr. Reddy's Laboratories

03 1Supriya Lifescience

04 22care4

05 1Adalvo

06 3Biocon

07 1Biogaran

08 2Cipla

09 2Cipla Medpro South Africa

10 1Fresenius Kabi USA

11 1Hangzhou Jiuyuan Gene Engineering

12 1Hikma Pharmaceuticals

13 1Lupin Ltd

14 1Nanjing King-friend Biochemical Pharmaceutical

15 2Newbury Pharmaceuticals Ab

16 33Novo Nordisk

17 2ORBICULAR

18 1ORIFARM GROUP AS

19 1Pharmathen SA

20 1Savior Lifetec Corporation

21 3Sun Pharmaceutical Industries Limited

22 1Teva Pharmaceutical Industries

23 1Viatris

24 1Wanbang Biopharmaceuticals

25 8Zentiva

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEuropean CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Regulatory Info : Approved

Registration Country : Sweden

Liraglutide

Brand Name : Polidia

Dosage Form : Solution For Injection

Dosage Strength : 6mg/ml

Packaging :

Approval Date : 05-12-2025

Application Number : 2.03E+13

Regulatory Info : Approved

Registration Country : Sweden

Polpharma CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info :

Registration Country : India

Liraglutide

Brand Name : Liraglutide

Dosage Form : Injectable

Dosage Strength : 6 mg/ml (3 ml)

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Dr Reddy Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSupriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.

Regulatory Info :

Registration Country : India

Liraglutide

Brand Name :

Dosage Form :

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Supriya

04

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LIRAGLUTIDE

Brand Name : LIRAGLUTIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2026-03-11

Application Number : 215245

Regulatory Info : RX

Registration Country : USA

blank

05

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LIRAGLUTIDE

Brand Name : LIRAGLUTIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2026-02-24

Application Number : 217063

Regulatory Info : RX

Registration Country : USA

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LIRAGLUTIDE

Brand Name : LIRAGLUTIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2026-03-30

Application Number : 212552

Regulatory Info : RX

Registration Country : USA

blank

07

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Liraglutide

Brand Name :

Dosage Form : Pen Injector

Dosage Strength : 18MG/3ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : China

blank

08

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LIRAGLUTIDE

Brand Name : LIRAGLUTIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2024-12-23

Application Number : 215503

Regulatory Info : RX

Registration Country : USA

blank

09

LIRAGLUTIDE

Brand Name : LIRAGLUTIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2025-07-22

Application Number : 215421

Regulatory Info : RX

Registration Country : USA

blank

10

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LIRAGLUTIDE

Brand Name : LIRAGLUTIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2025-04-02

Application Number : 218115

Regulatory Info : RX

Registration Country : USA

blank

11

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LIRAGLUTIDE

Brand Name : VICTOZA

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2010-01-25

Application Number : 22341

Regulatory Info : RX

Registration Country : USA

blank

12

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LIRAGLUTIDE

Brand Name : SAXENDA

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2014-12-23

Application Number : 206321

Regulatory Info : RX

Registration Country : USA

blank

13

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

INSULIN DEGLUDEC; LIRAGLUTIDE

Brand Name : XULTOPHY 100/3.6

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 300 UNITS/3ML;10.8MG/3ML (100 UNITS/ML;3.6MG/ML)

Packaging :

Approval Date :

Application Number : 208583

Regulatory Info :

Registration Country : USA

blank

14

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Liraglutide

Brand Name : Victoza

Dosage Form : Liraglutide 6Mg/Ml 3Ml 2 Units Parenteral Use

Dosage Strength : 2 pens SC 3 ml 6 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

15

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Liraglutide

Brand Name :

Dosage Form : Solution For Injection

Dosage Strength : 6MG/ML

Packaging : Pre-filled Pen

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Greece

blank

16

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Liraglutide

Brand Name :

Dosage Form :

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Taiwan

blank

17

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

LIRAGLUTIDE

Brand Name : LIRAGLUTIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2025-08-27

Application Number : 214568

Regulatory Info : RX

Registration Country : USA

blank

18

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

Liraglutide

Brand Name :

Dosage Form : Injection

Dosage Strength : 18MG/3ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : China

blank

19

ORBICULAR

Country
PEGS Boston Summit
Not Confirmed
arrow

ORBICULAR

Country
arrow
PEGS Boston Summit
Not Confirmed

LIRAGLUTIDE

Brand Name : LIRAGLUTIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2026-02-24

Application Number : 217234

Regulatory Info : RX

Registration Country : USA

blank

20

ORBICULAR

Country
PEGS Boston Summit
Not Confirmed
arrow

ORBICULAR

Country
arrow
PEGS Boston Summit
Not Confirmed

LIRAGLUTIDE

Brand Name : LIRAGLUTIDE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 18MG/3ML (6MG/ML)

Packaging :

Approval Date : 2026-01-14

Application Number : 217590

Regulatory Info : RX

Registration Country : USA

blank